Joel S. Marcus, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 52,357 shares at $67.83 ($3.6M) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Open-market sale of $3.6M ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.83 | 8,371 | $568K | 15.8% |
| 2 | $67.83 | 8,371 | $568K | 15.8% |
| 3 | $69.07 | 17,658 | $1.2M | 33.9% |
| 4 | $69.07 | 17,658 | $1.2M | 33.9% |
| 5 | $69.60 | 299 | $21K | 0.6% |
| Total | $68.68 avg | 52,357 |
| $3.6M |
| 100% |
| Filing → |
| ARE | BUY | 2026-05-07 | $348K | — | Filing → |
| ARE | BUY | 2026-05-06 | $320K | — | Filing → |
| ARE | BUY | 2026-05-05 | $410K | — | Filing → |